Regeneron Pharmaceuticals (NASDAQ:REGN) reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
Regeneron Pharmaceuticals beat estimated earnings by 14.44%, reporting an EPS of $11.49 versus an estimate of $10.04.
Revenue was up $436.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $5.61 which was followed by a 0.37% increase in the share price the next day.
Here's a look at Regeneron Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 18.11 | 9.49 | 17.69 | 9.03 |
| EPS Actual | 23.72 | 15.37 | 25.80 | 9.89 |
| Revenue Estimate | 4.47B | 2.79B | 3.89B | 2.56B |
| Revenue Actual | 4.95B | 3.45B | 5.14B | 2.53B |
To track all earnings releases for Regeneron Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
